Skip to content

A randomized, non blind, non intervention, parallel controlled clinical trial of Bifidobacterium Lactobacillus M8 in childhood asthma

A randomized, non blind, non intervention, parallel controlled clinical trial of Bifidobacterium Lactobacillus M8 in childhood asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017252
Enrollment
Unknown
Registered
2018-07-19
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood asthma

Interventions

Experience group :Bifidobacterium lactis M8
control group:No Bifidobacterium lactis M8

Sponsors

Weihai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. age 3 to 5 years old boy and girl; 2. had a history of asthma, shortness of breath, shortness of breath, or more than 24 hours of coughing, and had previously used bronchodilators to treat respiratory problems or had been diagnosed with asthma; 3. in line with the guidelines for diagnosis and prevention of bronchial asthma in children (2016), diagnostic criteria for asthma in children aged 6 years or younger.

Exclusion criteria

Exclusion criteria: 1. congenital diseases such as congenital heart disease and congenital immunodeficiency; 2. glucocorticoids, antihistamines and immunomodulators were used within 2 weeks before treatment; 3. during the follow-up period, those who stopped or adjusted the subjects randomly; 4. during follow-up period, antibiotics are needed for acute respiratory diseases such as pneumonia; 5. patients received other clinical trials at the same time; 6. suffering from chronic digestive system diseases, such as peptic ulcer, inflammatory bowel disease and severe liver disease; 7. patients with malignant tumors, such as hematological diseases; 8. allergic reaction to the sample or obvious gastrointestinal symptoms such as intolerance; 9. patients who refused to sign the informed consent form; 10. patients who took antibiotics during the follow-up period; 11. during the follow-up period, patients with irregular eating habits and more variable patients 12. chest radiographs showed pneumonia, bronchitis and other diseases; 13. in the near February, those who had diarrhea or who took probiotics preparations; 14. the use of antibiotics within 5 D before admission; 15. researchers believe that it is not suitable for the participants.

Design outcomes

Primary

MeasureTime frame
Asthma symptom score;

Secondary

MeasureTime frame
TRACK;DNA of gut microbiome;Eosinophil;

Countries

China

Contacts

Public ContactZhang Bing

Weihai Municipal Hospital

973519487@qq.com+86 13326311453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026